NasdaqCM - Delayed Quote USD
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
8.83
-0.34
(-3.71%)
At close: June 13 at 4:00:02 PM EDT
8.83
0.00
(0.00%)
After hours: June 13 at 6:47:48 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -1.33 | -1.36 | -5.29 | -4.84 |
| Low Estimate | -1.65 | -1.65 | -6.46 | -6.51 |
| High Estimate | -0.86 | -0.95 | -3.65 | -2.42 |
| Year Ago EPS | -0.9 | -1.15 | -3.68 | -5.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -- | -- | 1.11M | 4.11M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 10M | 25M |
| Year Ago Sales | -- | -- | -- | 1.11M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 270.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.19 | -0.95 | -1.26 | -1.07 |
| EPS Actual | -0.9 | -1.15 | -0.78 | -1.39 |
| Difference | 0.29 | -0.2 | 0.48 | -0.32 |
| Surprise % | 24.26% | -20.73% | 38.04% | -29.56% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.33 | -1.36 | -5.29 | -4.84 |
| 7 Days Ago | -1.33 | -1.36 | -5.29 | -4.84 |
| 30 Days Ago | -1.34 | -1.42 | -4.99 | -4.68 |
| 60 Days Ago | -1.34 | -1.42 | -4.99 | -4.68 |
| 90 Days Ago | -1.59 | -1.69 | -5.68 | -5.58 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 1 | 3 |
| Up Last 30 Days | 2 | 1 | 1 | 3 |
| Down Last 7 Days | 4 | 5 | 6 | 3 |
| Down Last 30 Days | 4 | 5 | 6 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CRBP | -47.65% | -18.07% | -43.87% | 8.60% |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Upgrades & Downgrades
| Maintains | RBC Capital: Outperform to Outperform | 5/7/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/7/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Maintains | Jefferies: Buy to Buy | 3/11/2025 |
| Initiated | William Blair: Outperform | 2/28/2025 |
Related Tickers
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
IKNA Ikena Oncology, Inc.
1.3500
-1.46%
KROS Keros Therapeutics, Inc.
13.56
-0.59%
ACRS Aclaris Therapeutics, Inc.
1.4700
-3.92%
PYXS Pyxis Oncology, Inc.
1.2000
-1.64%
DYN Dyne Therapeutics, Inc.
14.41
-0.35%
CTMX CytomX Therapeutics, Inc.
2.7500
-8.03%
RPTX Repare Therapeutics Inc.
1.4670
+1.87%
ASMB Assembly Biosciences, Inc.
16.85
-1.46%
TVRD Tvardi Therapeutics, Inc.
24.62
-5.71%